191 related articles for article (PubMed ID: 37031775)
1. Anti-immunoglobulin E for food allergy.
Dantzer JA; Wood RA
Ann Allergy Asthma Immunol; 2023 Jul; 131(1):11-22. PubMed ID: 37031775
[TBL] [Abstract][Full Text] [Related]
2. Omalizumab in IgE-Mediated Food Allergy: A Systematic Review and Meta-Analysis.
Zuberbier T; Wood RA; Bindslev-Jensen C; Fiocchi A; Chinthrajah RS; Worm M; Deschildre A; Fernandez-Rivas M; Santos AF; Jaumont X; Tassinari P
J Allergy Clin Immunol Pract; 2023 Apr; 11(4):1134-1146. PubMed ID: 36529441
[TBL] [Abstract][Full Text] [Related]
3. Combining Anti-IgE Monoclonal Antibodies and Oral Immunotherapy for the Treatment of Food Allergy.
Guilleminault L; Michelet M; Reber LL
Clin Rev Allergy Immunol; 2022 Feb; 62(1):216-231. PubMed ID: 34550555
[TBL] [Abstract][Full Text] [Related]
4. Combining anti-IgE with oral immunotherapy.
Lin C; Lee IT; Sampath V; Dinakar C; DeKruyff RH; Schneider LC; Nadeau KC
Pediatr Allergy Immunol; 2017 Nov; 28(7):619-627. PubMed ID: 28782296
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Outcome of Peanut Oral Immunotherapy Facilitated Initially by Omalizumab.
Yee CSK; Albuhairi S; Noh E; El-Khoury K; Rezaei S; Abdel-Gadir A; Umetsu DT; Burke-Roberts E; LeBovidge J; Schneider L; Rachid R
J Allergy Clin Immunol Pract; 2019 Feb; 7(2):451-461.e7. PubMed ID: 30267889
[TBL] [Abstract][Full Text] [Related]
6. The Use of Omalizumab in Food Oral Immunotherapy.
Labrosse R; Graham F; Des Roches A; Bégin P
Arch Immunol Ther Exp (Warsz); 2017 Jun; 65(3):189-199. PubMed ID: 27628022
[TBL] [Abstract][Full Text] [Related]
7. New biologics for food allergy.
Schuetz JP; Anderson B; Sindher SB
Curr Opin Allergy Clin Immunol; 2024 Jun; 24(3):147-152. PubMed ID: 38547423
[TBL] [Abstract][Full Text] [Related]
8. Oral and Sublingual Immunotherapy for Treatment of IgE-Mediated Food Allergy.
Scurlock AM
Clin Rev Allergy Immunol; 2018 Oct; 55(2):139-152. PubMed ID: 29656306
[TBL] [Abstract][Full Text] [Related]
9. Omalizumab as an adjuvant in food allergen immunotherapy.
Dantzer JA; Wood RA
Curr Opin Allergy Clin Immunol; 2021 Jun; 21(3):278-285. PubMed ID: 33605614
[TBL] [Abstract][Full Text] [Related]
10. Exploring novel approaches to food allergy management.
Howard-Ruben J; Doucette J
J Am Assoc Nurse Pract; 2023 Dec; 35(12):843-852. PubMed ID: 37335848
[TBL] [Abstract][Full Text] [Related]
11. Role of biologics in severe food allergy.
Dinardo G; Cafarotti A; Fierro V; Artesani MC; Indolfi C; Miraglia Del Giudice M; Fiocchi A
Curr Opin Allergy Clin Immunol; 2024 Jun; 24(3):138-143. PubMed ID: 38538153
[TBL] [Abstract][Full Text] [Related]
12. Oral immunotherapy and potential treatment.
Sato S; Yanagida N; Ebisawa M
Chem Immunol Allergy; 2015; 101():106-13. PubMed ID: 26022870
[TBL] [Abstract][Full Text] [Related]
13. Allergen-specific oral immunotherapy for peanut allergy.
Nurmatov U; Venderbosch I; Devereux G; Simons FE; Sheikh A
Cochrane Database Syst Rev; 2012 Sep; (9):CD009014. PubMed ID: 22972130
[TBL] [Abstract][Full Text] [Related]
14. Determinants of omalizumab dose-related efficacy in oral immunotherapy: Evidence from a cohort of 181 patients.
Azzano P; Paquin M; Langlois A; Morin C; Parizeault G; Lacombe-Barrios J; Samaan K; Graham F; Paradis L; Des Roches A; Bégin P
J Allergy Clin Immunol; 2021 Jan; 147(1):233-243. PubMed ID: 32980425
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic correlates of clinical responses to omalizumab in the setting of oral immunotherapy for milk allergy.
Frischmeyer-Guerrerio PA; Masilamani M; Gu W; Brittain E; Wood R; Kim J; Nadeau K; Jarvinen KM; Grishin A; Lindblad R; Sampson HA
J Allergy Clin Immunol; 2017 Oct; 140(4):1043-1053.e8. PubMed ID: 28414061
[TBL] [Abstract][Full Text] [Related]
16. New evidence in food allergies treatment.
Ghelli C; Costanzo G; Canonica GW; Heffler E; Paoletti G
Curr Opin Allergy Clin Immunol; 2024 Aug; 24(4):251-256. PubMed ID: 38814736
[TBL] [Abstract][Full Text] [Related]
17. Food oral immunotherapy: Any distinguishing factors predicting the need of anti-IgE?
Akarcan SE; Şenol HD; Gülen F; Demir E
Allergol Immunopathol (Madr); 2023; 51(6):104-111. PubMed ID: 37968804
[TBL] [Abstract][Full Text] [Related]
18. Anti-IgE treatment with oral immunotherapy in multifood allergic participants: a double-blind, randomised, controlled trial.
Andorf S; Purington N; Block WM; Long AJ; Tupa D; Brittain E; Rudman Spergel A; Desai M; Galli SJ; Nadeau KC; Chinthrajah RS
Lancet Gastroenterol Hepatol; 2018 Feb; 3(2):85-94. PubMed ID: 29242014
[TBL] [Abstract][Full Text] [Related]
19. The Role of Biologics in the Treatment of Food Allergy.
Sindher SB; Fiocchi A; Zuberbier T; Arasi S; Wood RA; Chinthrajah RS
J Allergy Clin Immunol Pract; 2024 Mar; 12(3):562-568. PubMed ID: 38013157
[TBL] [Abstract][Full Text] [Related]
20. Current Status of Potential Therapies for IgE-Mediated Food Allergy.
Parrish CP; Har D; Andrew Bird J
Curr Allergy Asthma Rep; 2018 Feb; 18(3):18. PubMed ID: 29470658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
